Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

75.22EUR
5:36am EDT
Change (% chg)

€1.19 (+1.61%)
Prev Close
€74.03
Open
€74.97
Day's High
€75.78
Day's Low
€74.53
Volume
1,339,967
Avg. Vol
3,662,959
52-wk High
€118.04
52-wk Low
€69.40

Chart for

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and... (more)

Overall

Beta: 1.10
Market Cap(Mil.): €69,036.82
Shares Outstanding(Mil.): 932.55
Dividend: 2.76
Yield (%): 3.72

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 19.12 30.14 32.45
EPS (TTM): 3.87 -- --
ROI: 4.06 12.95 12.63
ROE: 8.67 14.92 14.80

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Sep 19 2018

Factbox: Bayer's Monsanto faces broad U.S. glyphosate litigation

Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the company's glyphosate-based weed-killers, including the widely-used Roundup brand, caused his cancer.

Sep 19 2018

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Sep 19 2018

Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

Sept 18 Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer.

Sep 19 2018

Bayer says agriculture trade flows may change amid tariffs dispute

MONHEIM, Germany, Sept 18 Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities.

Sep 18 2018

Exclusive: Bayer puts stake in chemical park operator up for sale - sources

FRANKFURT Bayer is inviting financial investors to bid for its 60 percent stake in chemical park operator Currenta after initially failing to agree a sale to its former chemicals subsidiary Covestro, three people familiar with the matter told Reuters.

Sep 17 2018

Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will join Sanofi to stem a decline in prices in the French drugmaker's anti-diabetics and established drugs.

Sep 13 2018

UPDATE 1-Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT, Sept 13 Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will join Sanofi to stem a decline in prices in the French drugmaker's anti-diabetics and established drugs.

Sep 13 2018

Bayer's pharma unit head Weinand quits to join Sanofi

FRANKFURT, Sept 13 The head of Bayer's pharmaceuticals division Dieter Weinand will quit to joint Sanofi to head the French drugmaker's new Primary Care unit.

Sep 13 2018

Bayer adds label warning after death linked to stomach relief drops

FRANKFURT German drugmaker will add a warning of rare cases of liver damage to the label of prescription-free stomach relief drops Iberogast after Germany's drugs regulator said a death was linked to the product.

Sep 12 2018

Earnings vs. Estimates